Drug firm Unichem Laboratories today reported a 26.33 per cent rise in standalone net profit to Rs 26.10 crore for the quarter ended December 31, mainly on account of robust sales.
The company had posted a net profit of Rs 20.66 crore in the year—ago period, Unichem Laboratories said in a BSE filing.
Its total income on standalone basis from operations also rose to Rs 359.92 crore in the said quarter under as against Rs 309.21 crore a year ago.
Unichem Laboratories has strong presence in therapy areas of cardiology, neurology, orthopedics and anti—infectives.